|
|
||||||||
The Journal of Immunology, Vol 154, Issue 11 5896-5906, Copyright © 1995 by American Association of Immunologists
ARTICLES |
Y Ito, J Abe, K Yoshino, T Takeda and T Kohsaka
Department of Allergy and Immunology, National Children's Medical Research Center, Tokyo, Japan.
We previously reported that the Gram-negative bacterium Yersinia pseudotuberculosis produces a superantigen (YPM, Y. pseudotuberculosis- derived mitogen) that expands T cells bearing V betas 3, 9, 13.1, and 13.2 in an MHC class II-dependent manner. Based on the previously determined N-terminal 23 amino acids of YPM (T-D-Y-D-N-T-L-N-S-I-P-S-L- R-I-P-N-I-A-T-Y-T-G- (one-letter code)), we cloned the ypm gene and analyzed the nucleotide sequence. The gene encodes a 151-amino acid protein with a 20-amino acid signal peptide at its N terminus. The recombinant YPM expressed by the cloned gene exerted a mitogenic activity on human PBMC at a concentration of approximately 1 pg/ml. T cells bearing V beta 13.3 were preferentially expanded as well as T cells bearing the same V beta repertoires stimulated by native YPM. T cells were stimulated by the recombinant YPM in the presence of either fixed or unfixed HLA class II-transfected mouse fibroblasts. Furthermore, sequence diversity in the junctional region of the TCR beta-chain containing the V beta 3 element could be observed after stimulation by the recombinant YPM. These results indicate that YPM belongs to the category of superantigens and should be included as a novel member. The amino acid sequence of the mature protein showed no significant homology to other superantigens derived from Gram-positive bacteria such as Staphylococcus aureus and Streptococcus pyogenes. This observation, together with the substantially smaller m.w. suggest that ypm must have evolved from a different ancestral gene.
This article has been cited by other articles:
![]() |
M. Kreiss, A. Asmuss, K. Krejci, D. Lindemann, T. Miyoshi-Akiyama, T. Uchiyama, L. Rink, C. P. M. Broeren, and T. Herrmann Contrasting contributions of complementarity-determining region 2 and hypervariable region 4 of rat BV8S2+ (V{beta}8.2) TCR to the recognition of myelin basic protein and different types of bacterial superantigens Int. Immunol., May 1, 2004; 16(5): 655 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Proft, P. D. Webb, V. Handley, and J. D. Fraser Two Novel Superantigens Found in Both Group A and Group C Streptococcus Infect. Immun., March 1, 2003; 71(3): 1361 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fukushima, Y. Matsuda, R. Seki, M. Tsubokura, N. Takeda, F. N. Shubin, I. K. Paik, and X. B. Zheng Geographical Heterogeneity between Far Eastern and Western Countries in Prevalence of the Virulence Plasmid, the Superantigen Yersinia pseudotuberculosis-Derived Mitogen, and the High-Pathogenicity Island among Yersinia pseudotuberculosis Strains J. Clin. Microbiol., October 1, 2001; 39(10): 3541 - 3547. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Carnoy, C. Mullet, H. Muller-Alouf, E. Leteurtre, and M. Simonet Superantigen YPMa Exacerbates the Virulence of Yersinia pseudotuberculosis in Mice Infect. Immun., May 1, 2000; 68(5): 2553 - 2559. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |